Prospective evaluation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI plus bevacizumab (BV).
Chiara Cremolini
No relevant relationships to disclose
Fotios Loupakis
No relevant relationships to disclose
Dongyun Yang
No relevant relationships to disclose
Lisa Salvatore
No relevant relationships to disclose
Wu Zhang
No relevant relationships to disclose
Takeru Wakatsuki
No relevant relationships to disclose
Marta Schirripa
No relevant relationships to disclose
Sara Lonardi
No relevant relationships to disclose
Carlotta Antoniotti
No relevant relationships to disclose
Giuseppe Aprile
No relevant relationships to disclose
Gianluca Masi
No relevant relationships to disclose
Francesco Graziano
No relevant relationships to disclose
Annamaria Ruzzo
No relevant relationships to disclose
Sara Lucchesi
No relevant relationships to disclose
Monica Ronzoni
No relevant relationships to disclose
Martin Karl Herbert Maus
No relevant relationships to disclose
Guido Bocci
No relevant relationships to disclose
Giuseppe Tonini
No relevant relationships to disclose
Alfredo Falcone
No relevant relationships to disclose
Heinz-Josef Lenz
Consultant or Advisory Role - Bristol-Myers Squibb; Genentech; Merck KGaA